These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23915860)

  • 1. Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors.
    Terzic M; Dotlic J; Likic I; Brndusic N; Pilic I; Ladjevic N; Maricic S; Arsenovic N; Maricic Z
    Taiwan J Obstet Gynecol; 2013 Jun; 52(2):253-7. PubMed ID: 23915860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women.
    Ertas S; Vural F; Vural F; Tufekci EC; Ertas AC; Kose G; Aka N
    Asian Pac J Cancer Prev; 2016; 17(4):2177-83. PubMed ID: 27221915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of malignancy index in discrimination of adnexal masses.
    Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
    Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of a risk of malignancy index in clinical approaches to adnexal masses.
    Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
    Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
    van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the risk of malignancy index scoring systems (1-4) used in differential diagnosis of adnexal masses.
    Ozbay PO; Ekinci T; Caltekin MD; Yilmaz HT; Temur M; Yilmaz O; Uysal S; Demirel E; Kelekci S
    Asian Pac J Cancer Prev; 2015; 16(1):345-9. PubMed ID: 25640377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors.
    Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Thongsuksai P; Jaroenchainon P; Jivangkul C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S22-30. PubMed ID: 17718292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
    Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
    Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of malignancy index (RMI) in women with adnexal masses in Wales.
    Abdulrahman GO; McKnight L; Lutchman Singh K
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):376-81. PubMed ID: 25286794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of suspicious pelvic masses using the Pelvic Mass Index (PMI) scoring system from 2007 to 2014.
    Sinha A; Drews F; Lim K; Pugh ND
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():79-84. PubMed ID: 27082132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological diagnoses of adnexal masses: which parameters are relevant in preoperative assessment?
    Terzic M; Dotlic J; Brndusic N; Arsenovic N; Likic I; Ladjevic N; Maricic S; Andrijasevic S
    Ginekol Pol; 2013 Aug; 84(8):700-8. PubMed ID: 24191504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of parity to the risk of malignancy index score in evaluating adnexal masses.
    Yavuzcan A; Çağlar M; Özgü E; Üstün Y; Dilbaz S; Ozdemir I; Güngör T; Kumru S
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):518-22. PubMed ID: 25510694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adnexal masses: correlation between clinical, ultrasound and histopathological findings.
    Dotlić J; Terzić M; Likić I; Atanacković J; Ladjević N
    Vojnosanit Pregl; 2011 Oct; 68(10):861-6. PubMed ID: 22165752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of ultrasound as a diagnostic tool in the preoperative assessment of patients with adnexal masses.
    Terzic M; Dotlic J; Bila J; Pilic I; Nikolic B; Kocijancic D; Likic I; Arsenovic N; Mihailovic T; Bugarski D
    J BUON; 2015; 20(3):862-9. PubMed ID: 26214641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
    Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative multimodal strategies for risk assessment of adnexal masses: analysis of 1362 cases in a gynecologic cancer center.
    Radosa MP; Camara O; Vorwergk J; Diebolder H; Winzer H; Mothes A; Gajda M; Runnebaum IB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1056-62. PubMed ID: 21633301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses.
    Terzić M; Dotlić J; Ladjević IL; Atanacković J; Ladjević N
    Vojnosanit Pregl; 2011 Jul; 68(7):589-93. PubMed ID: 21899180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
    Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
    Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.